Sooyeon Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sooyeon Lee has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Justin P. Annes
Department of Medicine, Division of Endocrinology, Stanford University, Stanford, CA, USA
2 shared publications - Shannon L. Kelleher
Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA
2 shared publications - Ada S. Y. Poon
Affiliation Electrical Engineering Department, Stanford University, Stanford, California, United States of America
1 shared publication Aidan Van Vleck
Division of Endocrinology, Department of Medicine, Stanford University, Stanford, CA
1 shared publicationAlbert Mao Li
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
1 shared publicationAlex M. Mawla
Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, Davis, CA
1 shared publication
Latest Publications
- Open Access
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101292
Cdk5 ablation in osteoblast lineage increases osteocyte apoptosis in mice
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101292
Open AccessCdk5 ablation in osteoblast lineage increases osteocyte apoptosis in mice
- Open Access
- 26 April 2022
- Published by American Diabetes Association in Diabetes
- Vol. 71 (7) , 1439-1453
β-Cell Succinate Dehydrogenase Deficiency Triggers Metabolic Dysfunction and Insulinopenic Diabetes
Mitochondrial dysfunction plays a central role in type 2 diabetes (T2D); however, the pathogenic mechanisms in pancreatic β-cells are incompletely elucidated. Succinate dehydrogenase (SDH) is a key mitochondrial enzyme with dual functions in the tricarboxylic acid cycle and electron transport chain. Using samples from human with diabetes and a mouse model of β-cell–specific SDH ablation (SDHBβKO), we define SDH deficiency as a driver of mitochondrial dysfunction in β-cell failure and insulinopenic diabetes. β-Cell SDH deficiency impairs glucose-induced respiratory oxidative phosphorylation and mitochondrial membrane potential collapse, thereby compromising glucose-stimulated ATP production, insulin secretion, and β-cell growth. Mechanistically, metabolomic and transcriptomic studies reveal that the loss of SDH causes excess succinate accumulation, which inappropriately activates mammalian target of rapamycin (mTOR) complex 1–regulated metabolic anabolism, including increased SREBP-regulated lipid synthesis. These alterations, which mirror diabetes-associated human β-cell dysfunction, are partially reversed by acute mTOR inhibition with rapamycin. We propose SDH deficiency as a contributing mechanism to the progressive β-cell failure of diabetes and identify mTOR complex 1 inhibition as a potential mitigation strategy.
- 26 April 2022
- Published by American Diabetes Association in Diabetes
- Vol. 71 (7) , 1439-1453
Open Accessβ-Cell Succinate Dehydrogenase Deficiency Triggers Metabolic Dysfunction and Insulinopenic Diabetes
Mitochondrial dysfunction plays a central role in type 2 diabetes (T2D); however, the pathogenic mechanisms in pancreatic β-cells are incompletely elucidated. Succinate dehydrogenase (SDH) is a key mitochondrial enzyme with dual functions in the tricarboxylic acid cycle and electron transport chain. Using samples from human with diabetes and a mouse model of β-cell–specific SDH ablation (SDHBβKO), we define SDH deficiency as a driver of mitochondrial dysfunction in β-cell failure and insulinopenic diabetes. β-Cell SDH deficiency impairs glucose-induced respiratory oxidative phosphorylation and mitochondrial membrane potential collapse, thereby compromising glucose-stimulated ATP production, insulin secretion, and β-cell growth. Mechanistically, metabolomic and transcriptomic studies reveal that the loss of SDH causes excess succinate accumulation, which inappropriately activates mammalian target of rapamycin (mTOR) complex 1–regulated metabolic anabolism, including increased SREBP-regulated lipid synthesis. These alterations, which mirror diabetes-associated human β-cell dysfunction, are partially reversed by acute mTOR inhibition with rapamycin. We propose SDH deficiency as a contributing mechanism to the progressive β-cell failure of diabetes and identify mTOR complex 1 inhibition as a potential mitigation strategy.
- Open Access
- 9 December 2021
- Published by The Endocrine Society in Endocrinology
- Vol. 163 (2)
Novel Pathogenic De Novo INS p.T97P Variant Presenting With Severe Neonatal DKA
Pathogenic INS gene mutations are causative for mutant INS-gene-induced diabetes of youth (MIDY). We characterize a novel de novo heterozygous INS gene mutation (c.289A>C, p.T97P) that presented in an autoantibody-negative 5-month-old male infant with severe diabetic ketoacidosis. In silico pathogenicity prediction tools provided contradictory interpretations, while structural modeling indicated a deleterious effect on proinsulin folding. Transfection of wildtype and INS p.T97P expression and luciferase reporter constructs demonstrated elevated intracellular mutant proinsulin levels and dramatically impaired proinsulin/insulin and luciferase secretion. Notably, proteasome inhibition partially and selectively rescued INS p.T97P-derived luciferase secretion. Additionally, expression of INS p.T97P caused increased intracellular proinsulin aggregate formation and XBP-1s protein levels, consistent with induction of endoplasmic reticulum stress. We conclude that INS p.T97P is a newly identified pathogenic A-chain variant that is causative for MIDY via disruption of proinsulin folding and processing with induction of the endoplasmic reticulum stress response.
- 9 December 2021
- Published by The Endocrine Society in Endocrinology
- Vol. 163 (2)
Open AccessNovel Pathogenic De Novo INS p.T97P Variant Presenting With Severe Neonatal DKA
Pathogenic INS gene mutations are causative for mutant INS-gene-induced diabetes of youth (MIDY). We characterize a novel de novo heterozygous INS gene mutation (c.289A>C, p.T97P) that presented in an autoantibody-negative 5-month-old male infant with severe diabetic ketoacidosis. In silico pathogenicity prediction tools provided contradictory interpretations, while structural modeling indicated a deleterious effect on proinsulin folding. Transfection of wildtype and INS p.T97P expression and luciferase reporter constructs demonstrated elevated intracellular mutant proinsulin levels and dramatically impaired proinsulin/insulin and luciferase secretion. Notably, proteasome inhibition partially and selectively rescued INS p.T97P-derived luciferase secretion. Additionally, expression of INS p.T97P caused increased intracellular proinsulin aggregate formation and XBP-1s protein levels, consistent with induction of endoplasmic reticulum stress. We conclude that INS p.T97P is a newly identified pathogenic A-chain variant that is causative for MIDY via disruption of proinsulin folding and processing with induction of the endoplasmic reticulum stress response.
- 1 December 2016
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 611, 86-92
Molecular regulation of lactation: The complex and requisite roles for zinc
- 1 December 2016
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 611, 86-92
Molecular regulation of lactation: The complex and requisite roles for zinc
- Open Access
- 1 April 2014
- Published by Wiley in The FASEB Journal
- Vol. 28 (S1) , 1043.3
Marginal zinc intake impairs mammary gland involution, increases oxidative stress and disrupts ductal integrity abrogating the protective effect of lactation on breast tumorigenesis in a mouse model (1043.3)
Breast cancer is the most common cancer among women. While breastfeeding can reduce breast cancer risk, several studies found no protective effect. We showed that marginal zinc (Zn) intake compromises mammary gland (MG) expansion and function during lactation and is associated with hallmarks of pre‐neoplastic lesions such as collagen deposition, macrophage infiltration, and ductal hyperplasia in the MG of nulliparous mice. Herein, we hypothesized that marginal Zn deficiency abrogates the protective effect of breastfeeding on breast cancer risk. C57BL/6 mice were fed a Zn adequate (ZA; 30mg Zn/kg) or Zn deficient (ZD; 15mg Zn/ kg) diet. Mice were bred, and 2 wk post‐weaning were gavaged with 7,12‐dimethylbenzanthracene (DMBA; 1mg/0.1mL corn oil) or corn oil (control) weekly for 4 wk. Tumor progression was monitored for 24 wk. ZD mice had lower matrix metalloproteinase 2 activity (p Grant Funding Source : Intramural support, Departments of Surgery and Nutritional Sciences, Penn State University
- 1 April 2014
- Published by Wiley in The FASEB Journal
- Vol. 28 (S1) , 1043.3
Open AccessMarginal zinc intake impairs mammary gland involution, increases oxidative stress and disrupts ductal integrity abrogating the protective effect of lactation on breast tumorigenesis in a mouse model (1043.3)
Breast cancer is the most common cancer among women. While breastfeeding can reduce breast cancer risk, several studies found no protective effect. We showed that marginal zinc (Zn) intake compromises mammary gland (MG) expansion and function during lactation and is associated with hallmarks of pre‐neoplastic lesions such as collagen deposition, macrophage infiltration, and ductal hyperplasia in the MG of nulliparous mice. Herein, we hypothesized that marginal Zn deficiency abrogates the protective effect of breastfeeding on breast cancer risk. C57BL/6 mice were fed a Zn adequate (ZA; 30mg Zn/kg) or Zn deficient (ZD; 15mg Zn/ kg) diet. Mice were bred, and 2 wk post‐weaning were gavaged with 7,12‐dimethylbenzanthracene (DMBA; 1mg/0.1mL corn oil) or corn oil (control) weekly for 4 wk. Tumor progression was monitored for 24 wk. ZD mice had lower matrix metalloproteinase 2 activity (p Grant Funding Source : Intramural support, Departments of Surgery and Nutritional Sciences, Penn State University
- Open Access
- 1 January 2009
- Published by Japanese Society of Applied Entomology & Zoology in Applied Entomology and Zoology
- Vol. 44 (4) , 515-523
Temperature-dependent development and oviposition models of Riptortus clavatus (Thunberg) (Hemiptera: Alydidae)
- 1 January 2009
- Published by Japanese Society of Applied Entomology & Zoology in Applied Entomology and Zoology
- Vol. 44 (4) , 515-523
Open AccessTemperature-dependent development and oviposition models of Riptortus clavatus (Thunberg) (Hemiptera: Alydidae)